Puberty Is Not a Disease: Why the Pathways Trial Should Not Proceed
Children as young as 11 could soon be recruited as the NHS resumes the Pathways puberty blocker trial despite continuing concerns over long-term risks! In December 2025 we reported that a proposed ‘puberty blocker’ trial had been halted because use of such drugs pose unknown psychological and physiological side effects. However, in a devastating blow…










